| BsAb | Bispecific antibodies |
|---|---|
| BSAb | Bispecific antibody |
| Bi-MAbs | Bispecific monoclonal antibodies |
| BsMab | Bispecific monoclonal antibody |
| antibodies, bispecific | Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate antigenic determinants. They are artificial antibodies produced by chemical crosslinking, fusion of hybridoma cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabelled haptens, and effector cells to diseased tissue, primarily tumours. (12 Dec 1998) |
|---|
| bispecific antibody |
An engineered antibody with two different binding sites that recognize two different antigens.
출처: www.genpromag.com/Glossary~LETTER~B.html
|
|---|---|
| bispecific antibody |
An antibody developed in the laboratory to recognize more than one protein on different cells. Some examples are bispecific antibodies 2B I, 52OC9xH22, MDX-H210, and MDX447.
출처: nydailynews.healthology.com/nydailynews/15836.htm
|
| bispecific a. |
antibody in which each of two antigen-binding sites is specific for separate antigenic determinants. It is an artificial antibody produced in the laboratory, formed by reassociating half molecules of two different antibody specificities to form a hybrid or bispecific antibody with antigen-binding sites of separate specificities. Called also hybrid a.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|